IP Verse

Crystalline Forms Of An Androgen Receptor Modulator

Patent No. EP3348553 (titled "Crystalline Forms Of An Androgen Receptor Modulator") was filed by Aragon Pharmaceuticals on Jun 4, 2013. The application was issued on Jul 8, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZApr 8, 2021TER MEER STEINMEISTER & PARTNER
SCORPIOApr 8, 2021SAGITTARIUS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3348553

ARAGON PHARMACEUTICALS
Application Number
EP18157435A
Filing Date
Jun 4, 2013
Status
Revoked
Jul 31, 2024
Publication Date
Jul 8, 2020
External Links
Slate, Register , Google Patents